Trump's drug czar nominee withdraws after opioid report

October 17, 2017

President Trump announced Tuesday that his nominee for drug czar, Rep. Tom Marino, has withdrawn his name from consideration for the position. The announcement came following a joint investigation by CBS' "60 Minutes" and The Washington Post on the opioid crisis.

tommarino.jpeg

© AP Photo/Susan Walsh

The report found that Congress helped disarm the Drug Enforcement Administration during the height of the crisis. Marino, R-Pennsylvania, was the chief advocate for the bill at the center of the investigation.

The bill weakened the DEA's control over opioid drug distributors," reports CBS news.


Comment on This Article   

Post Your Comment

Please check your e-mail for a link to activate your account.

Related Articles

Substance Abuse, A Mental Health Issue
The New Plan for Taking on Drug Pricing
Trump declares opioids a public health emergency

Featured Articles

Surprise Billing: Arbitration Will Raise Your Premiums
SB 432 – Lots of Treats for Pharmacists – and Bad News for Consumers
Why do Pharmaceutical Companies hate PBMs so much?
Creators of Mysterious Ad Blitz Influencing Anti-Surprise Billing Law Comes to Light
Benchmarking, Not Arbitration, is the Answer to America’s Surprise Billing Problem
Podcast: Senator Joyce Krawiec Talks to Us About Why CON Laws are Bad for NC